Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016 (2016), Article ID 2063103, 8 pages
http://dx.doi.org/10.1155/2016/2063103
Research Article

Serum Oxidized LDL Levels in Type 2 Diabetic Patients with Retinopathy in Mthatha Region of the Eastern Cape Province of South Africa

Division of Medical Biochemistry, Department of Human Biology, Faculty of Health Sciences, Walter Sisulu University, Mthatha Campus, Nelson Mandela Drive, Mthatha 5100, South Africa

Received 28 March 2016; Revised 11 May 2016; Accepted 25 May 2016

Academic Editor: Giuseppe Cirillo

Copyright © 2016 Farzana Ganjifrockwala et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. E. Wold, A. F. Ceylan-Isik, and J. Ren, “Oxidative stress and stress signaling: menace of diabetic cardiomyopathy,” Acta Pharmacologica Sinica, vol. 26, no. 8, pp. 908–917, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. R. A. Kowluru and P.-S. Chan, “Oxidative stress and diabetic retinopathy,” Experimental Diabesity Research, vol. 2007, Article ID 43603, 12 pages, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Amod, B. H. Ascott-Evans, G. I. Berg et al., “The 2012 SEMDSA guideline for the management of type 2 diabetes (revised),” Journal of Endocrinology, Metabolism and Diabetes of South Africa, vol. 17, no. 2, pp. S1–S95, 2012. View at Publisher · View at Google Scholar
  4. Y. Lin and Z. Sun, “Current views on type 2 diabetes,” Journal of Endocrinology, vol. 204, pp. 1–11, 2010. View at Publisher · View at Google Scholar
  5. C. N. Hales, “Non-insulin-dependent diabetes mellitus,” British Medical Bulletin, vol. 53, no. 1, pp. 109–122, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. S. A. Madsen-Bouterse and R. A. Kowluru, “Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives,” Reviews in Endocrine and Metabolic Disorders, vol. 9, no. 4, pp. 315–327, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Wu, L. Tang, and B. Chen, “Oxidative stress: implications for the development of diabetic retinopathy and antioxidant therapeutic perspectives,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 752387, 12 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. E. S. Shin, C. M. Sorenson, and N. Sheibani, “Diabetes and retinal vascular dysfunction,” Journal of Ophthalmic and Vision Research, vol. 9, no. 3, pp. 362–373, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Rema and R. Pradeepa, “Diabetic retinopathy: an Indian perspective,” Indian Journal of Medical Research, vol. 125, no. 3, pp. 297–310, 2007. View at Google Scholar · View at Scopus
  10. M. J. Fowler, “Microvascular and macrovascular complications of diabetes,” Clinical Diabetes, vol. 26, no. 2, pp. 77–82, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. Y.-C. Chang and W.-C. Wu, “Diabetic retinopathy: an Indian perspective,” Review of Diabetic Studies, vol. 10, no. 2-3, pp. 121–132, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Merzouk, A. Hichami, A. Sari et al., “Impaired oxidant/antioxidant status and LDL-fatty acid composition are associated with increased susceptibility to peroxidation of LDL in diabetic patients,” General Physiology and Biophysics, vol. 23, no. 4, pp. 387–399, 2004. View at Google Scholar · View at Scopus
  13. S. Parthasarathy, A. Raghavamenon, M. O. Garelnabi, and N. Santanam, “Oxidized low density lipoprotein,” Methods in Molecular Biology, vol. 610, pp. 403–417, 2010. View at Google Scholar
  14. E. E. M. Nour Eldin, A. Almarzouki, A. M. Assiri, O. M. Elsheikh, B. E. A. Mohamed, and A. T. Babakr, “Oxidized low density lipoprotein and total antioxidant capacity in type-2 diabetic and impaired glucose tolerance Saudi men,” Diabetology and Metabolic Syndrome, vol. 6, article 94, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. A. N. Orekhov, Y. V. Bobryshev, I. A. Sobenin, A. A. Melnichenko, and D. A. Chistiakov, “Modified low density lipoprotein and lipoprotein-containing circulating immune complexes as diagnostic and prognostic biomarkers of atherosclerosis and type 1 diabetes macrovascular disease,” International Journal of Molecular Sciences, vol. 15, no. 7, pp. 12807–12841, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Y. Yu and T. J. Lyons, “Modified lipoproteins in diabetic retinopathy: a local action in the retina,” Journal of Clinical and Experimental Ophthalmology, vol. 4, article 314, 2013. View at Publisher · View at Google Scholar
  17. D. Fu, J. Y. Yu, M. Wu et al., “Immune complex formation in human diabetic retina enhances toxicity of oxidized LDL towards retinal capillary pericytes,” The Journal of Lipid Research, vol. 55, no. 5, pp. 860–869, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. A. T. Kharroubi, H. M. Darwish, M. A. Akkawi et al., “Total antioxidant status in type 2 diabetic patients in Palestine,” Journal of Diabetes Research, vol. 2015, Article ID 461271, 7 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Pasupathi, G. Bakthavathsalam, G. Saravanan, and R. Latha, “Evaluation of oxidative stress and antioxidant status in patients with diabetes mellitus,” Journal of Applied Sciences Research, vol. 5, no. 7, pp. 770–775, 2009. View at Google Scholar · View at Scopus
  20. M. Benrebai, N. Abidli, S. M. Nasr, and C. Benlatreche, “Oxidative stress status in type 2 diabetic patients in Eastern Algeria,” World Applied Sciences Journal, vol. 4, no. 5, pp. 714–719, 2008. View at Google Scholar
  21. J. Nourooz-Zadeh, A. Rahimi, J. Tajaddini-Sarmadi et al., “Relationships between plasma measures of oxidative stress and metabolic control in NIDDM,” Diabetologia, vol. 40, no. 6, pp. 647–653, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. S.-C. Chen and C.-H. Tseng, “Dyslipidemia, kidney disease, and cardiovascular disease in diabetic patients,” The Review of Diabetic Studies, vol. 10, no. 2-3, pp. 88–100, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. E. C. Pereira, S. Ferderbar, M. C. Bertolami et al., “Biomarkers of oxidative stress and endothelial dysfunction in glucose intolerance and diabetes mellitus,” Clinical Biochemistry, vol. 41, no. 18, pp. 1454–1460, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Kuroki, K. Isshiki, and G. L. King, “Oxidative stress: the lead or supporting actor in the pathogenesis of diabetic complications,” Journal of the American Society of Nephrology, vol. 14, no. 8, supplement 3, pp. S216–S220, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. A. M. Vincent, J. W. Russell, P. Low, and E. L. Feldman, “Oxidative stress in the pathogenesis of diabetic neuropathy,” Endocrine Reviews, vol. 25, no. 4, pp. 612–628, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. G. S. R. Kedari, “Evaluation of thyroid status, oxidant stress and antioxidant status in patients with type 2 diabetes mellitus,” Journal of Clinical and Diagnostic Research, vol. 5, no. 2, pp. 254–255, 2011. View at Google Scholar · View at Scopus
  27. A. Jamuna Rani and S. V. Mythili, “Study on total antioxidant status in relation to oxidative stress in type 2 diabetes mellitus,” Journal of Clinical and Diagnostic Research, vol. 8, no. 3, pp. 108–110, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Z. A. Soliman, “Blood lipid peroxidation (superoxide dismutase, malondialdehyde, glutathione) levels in Egyptian type 2 diabetic patients,” Singapore Medical Journal, vol. 49, no. 2, pp. 129–136, 2008. View at Google Scholar · View at Scopus
  29. S. Shetty, N. Suchetha Kumari, and L. N. Madhu, “Oxidative stress, antioxidant status and DNA damage in type 2 diabetes mellitus,” Research Journal of Pharmaceutical, Biological and Chemical Sciences, vol. 4, no. 1, pp. 437–443, 2013. View at Google Scholar · View at Scopus
  30. M. E. Hartnett, R. D. Stratton, R. W. Browne, B. A. Rosner, R. J. Lanham, and D. Armstrong, “Serum markers of oxidative stress and severity of diabetic retinopathy,” Diabetes Care, vol. 23, no. 2, pp. 234–240, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Gurler, H. Vural, N. Yilmaz, H. Oguz, A. Satici, and N. Aksoy, “The role of oxidative stress in diabetic retinopathy,” Eye, vol. 14, no. 5, pp. 730–735, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Polak and Z. Zagórski, “Lipid peroxidation in diabetic retinopathy,” Annales Universitatis Mariae Curie-Skłodowska. Sectio D: Medicina, vol. 59, no. 1, pp. 434–437, 2004. View at Google Scholar · View at Scopus
  33. S. Kumari, S. Panda, M. Mangaraj, M. K. Mandal, and P. C. Mahapatra, “Plasma MDA and antioxidant vitamins in diabetic retinopathy,” Indian Journal of Clinical Biochemistry, vol. 23, no. 2, pp. 158–162, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Mandal, R. Bandyopadhyay, S. Chakrabarti, and T. K. Bandyopadhyay, “Assessment of oxidative stress in patients of diabetes mellitus with and without complications,” Journal, Indian Academy of Clinical Medicine, vol. 11, no. 1, pp. 20–25, 2010. View at Google Scholar · View at Scopus
  35. V. Desai, R. Shekhar, S. Prabodh, N. V. S. Chowdary, M. C. Das, and J. Reddy, “Oxidative stress in diabetic retinopathy,” Journal of Clinical and Diagnostic Research, vol. 5, no. 5, pp. 994–997, 2011. View at Google Scholar
  36. D. Kundu, T. Mandal, M. Nandi, M. Osta, U. Bandyopadhyay, and D. Ray, “Oxidative stress in diabetic patients with retinopathy,” Annals of African Medicine, vol. 13, no. 1, pp. 41–46, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Kawamura, J. W. Heinecke, and A. Chait, “Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway,” Journal of Clinical Investigation, vol. 94, no. 2, pp. 771–778, 1994. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Ono, “Effect of glycemic control on plasma oxidized low density lipoprotein levels in diabetics,” Science Journal of Clinical Medicine, vol. 3, no. 5, pp. 91–97, 2014. View at Publisher · View at Google Scholar
  39. S. Kopprasch, J. Pietzsch, E. Kuhlisch et al., “In vivo evidence for increased oxidation of circulating LDL in impaired glucose tolerance,” Diabetes, vol. 51, no. 10, pp. 3102–3106, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. P. Behzadi, F. Torabi, M. Amini, and A. Aminorroaya, “Comparison of ox-LDL levels in diabetic patients with normo-, micro-, and macroalbuminuria with their first degree relatives and the healthy control group,” International Journal of Endocrinology, vol. 2012, Article ID 167154, 5 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. P. V. Kiranmayi, N. Vivekanand, and V. L. Pandit, “The study of lipid profile and oxidized LDL in type 2 diabetes mellitus,” Scholars Journal of Applied Medical Sciences, vol. 2, no. 3, pp. 1119–1122, 2014. View at Google Scholar
  42. N. Asem and B. B. Asem, “The many faces of cholesterol: how modifications in LDL and HDL alter their potential to promote or prevent atherosclerosis,” The UCLA Undergraduate Science Journal, vol. 22, pp. 11–17, 2009. View at Google Scholar
  43. M. Tomás, G. Latorre, M. Sentí, and J. Marrugat, “The antioxidant function of high density lipoproteins: a new paradigm in atherosclerosis,” Revista Espanola de Cardiologia, vol. 57, no. 6, pp. 557–569, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. M. F. Lopes-Virella, N. L. Baker, K. J. Hunt, T. J. Lyons, A. J. Jenkins, and G. Virella, “High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes,” Diabetes Care, vol. 35, no. 6, pp. 1333–1340, 2012. View at Publisher · View at Google Scholar · View at Scopus